Morning Briefing
Summaries of health policy coverage from major news organizations
Powers Takes Permanent Helm At NIAID, Vows Return To 'Primary Mission' Of Studying Diseases
Stat: John Powers III Appointed Permanent Director Of NIAID
The acting director of the National Institute of Allergy and Infectious Diseases, John Powers III, will become the permanent director, the agency announced Monday. (Oza, 11/16)
The Washington Post: Trump Nominates Eric Ueland As Comptroller General
President Donald Trump has nominated Eric Ueland to serve as the next comptroller general of the United States, a key watchdog role that audits and investigates federal spending across government agencies. The nomination to head the Government Accountability Office is for a 15-year term, which means it will extend well into the next presidency. (Cook and Alfaro, 11/7)
The Washington Post: White House Weighs Next Steps For FDA Nominee Who Faces Bipartisan Pushback
Some Trump administration officials are growing skeptical that the Senate will confirm Heidi Overton to lead the Food and Drug Administration, prompting them to discuss whether to attempt to shore up her nomination or abandon it altogether, according to four people familiar with the matter who spoke on the condition of anonymity to discuss a personnel matter. (Roubein and Diamond, 11/16)
More Trump administration news —
Stat: In A Win For MAHA, FDA Creates New Regulatory Category For The Supplement NAC
The Food and Drug Administration is proposing a new classification for a product that’s existed in a legal gray area for years, a win for proponents of dietary supplements, including members of the MAHA movement. (Manto, 11/16)
Stat: RFK Jr. Pushes Federal Funding For Faith-Based Recovery Organizations
While campaigning the week before the midterms, health secretary Robert F. Kennedy Jr. visited Sheepgate, a Christian addiction recovery center in Colfax, Iowa. Sheepgate, Kennedy said, is a model for the type of faith-based center that doesn’t receive federal funding but that he believes should. (Gaffney, 11/17)
The New York Times: American Global Health Aid Isn’t Dead. It’s Changing
Americans might have assumed that their country was out of the business of promoting global health. On his first day in office, President Trump announced the United States’ withdrawal from the World Health Organization and abruptly “paused” foreign aid. Over the following weeks, Elon Musk took a chain saw to the U.S. Agency for International Development. In the wake of these actions, reporters documented shortages of tuberculosis, malaria and H.I.V. drugs, widespread clinic closures and the abandonment of patients enrolled in medical trials. Many programs never resumed, and researchers predicted that hundreds of thousands of avoidable deaths would occur in the first year alone. (Fink, 11/16)